Epsilon LLP is a Kazakhstan-based developer and manufacturer of veterinary pharmaceuticals. The company specializes in the development of modern veterinary products aimed at the prevention and treatment of diseases in livestock and companion animals.

Currently, Epsilon LLP has a portfolio of 5 registered veterinary products whose effectiveness has been confirmed through practical use in the veterinary sector of the Republic of Kazakhstan. The company’s products contribute to improving biosecurity in animal husbandry and enhancing veterinary welfare across the regions of the country.

A significant milestone in the company’s development was receiving grant funding from the Science Foundation JSC under the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan. This support enabled the company to scale up industrial production of veterinary pharmaceuticals, implement modern technologies, and expand its manufacturing capacity.

In addition, the company obtained credit financing under the “Orleu” program through ForteBank JSC. The attracted funds were directed toward expanding production and increasing output volumes, which strengthened the company’s position in the domestic market.

The company holds an active manufacturing license No. 22006273 dated 01.04.2022, confirming compliance with all regulatory requirements and quality standards.

Today, Epsilon LLP continues to actively develop, expand its product range, and make a significant contribution to the development of Kazakhstan’s agro-industrial complex.

West Kazakhstan Region, Uralsk city, T. Masin Street, building 89, apartment 1, office 1
+7 701 440 13 66
tooepsilon@gmail.com
https://epsilon.vet/